Skip to Content

WATSON 668 (Enalapril Maleate 2.5 mg)

Pill with imprint WATSON 668 is White, Round and has been identified as Enalapril Maleate 2.5 mg. It is supplied by Watson Pharmaceuticals.

Enalapril is used in the treatment of diabetic kidney disease; high blood pressure; heart failure; alport syndrome; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 668

Enalapril Maleate

Imprint:
WATSON 668
Strength:
2.5 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0668

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide